Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma

Mount Sinai Medical Center /ID# 133569, New York

Universitaetsklinikum Schleswig-Holstein /ID# 141534, Kiel

Hospital Universitario de la Princesa /ID# 140881, Madrid

Hospital Universitario 12 de Octubre /ID# 140878, Madrid

Clinica Universitaria de Navarra /ID# 141411, Pamplona-Navarra

Hospital Clinico Universitario Salamanca /ID# 140880, Salamanca

The Sarah Cannon Research Institute /ID# 135814, Nashville

CHU de Nantes, Hotel Dieu - HME /ID# 133633, Nantes

University of Michigan Medical Center /ID# 139402, Ann Arbor

Universitaetsklinikum Koeln /ID# 141535, Cologne

CHRU de Lille, Hopital Claude Huriez /ID# 133634, Lille

The University of Chicago Medical Center /ID# 139403, Chicago

Universitaetsklinikum Heidelberg /ID# 140046, Heidelberg

Universitaetsklinikum Tuebingen /ID# 141074, Tübingen

CHU de la miletrie, Centre d'investigation clinique /ID# 147542, Poitiers

Universitaetsklinikum Wuerzburg /ID# 141533, Würzburg

Washington University School of Medicine /ID# 135708, St Louis

Universitaetklinikum Dresden /ID# 141860, Dresden

Hospital Clinic de Barcelona /ID# 141643, Barcelona